FIREBRICK PHARMA LIMITED - Announcements

0.00%

6.5¢

Market Cap $16.27M

Healthcare Biotechnology

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on... Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available for sale in USA and Singapore.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

FRE	Final Director's Interest Notice - Phyllis Gardner		12/09/25	254.96KB	Share
FRE	Passing of Director - Phyllis Gardner		11/09/25	125.58KB	Share
FRE	Cleansing Notice		11/09/25	131.46KB	Share
FRE	Application for quotation of securities - FRE		11/09/25	15.81KB	Share
FRE	Firebrick receives $250,000 R&D Tax Incentive	PRICE SENSITIVE	10/09/25	127.6KB	Share
FRE	Ceasing to be a substantial holder - Pharma Nutria NA Inc		02/09/25	317.39KB	Share
FRE	Change in substantial holding		01/09/25	111.3KB	Share
FRE	Change in substantial holding - Peter Molloy		29/08/25	278.08KB	Share
FRE	Change in substantial holding - Stephen Goodall		29/08/25	188.32KB	Share
FRE	Ceasing to be a substantial holder - Firebrick Pharma		29/08/25	203.91KB	Share
FRE	Cleansing Notice		29/08/25	131.56KB	Share
FRE	Notification regarding unquoted securities - FRE		29/08/25	14.45KB	Share
FRE	Application for quotation of securities - FRE		29/08/25	15.7KB	Share
FRE	Application for quotation of securities - FRE		29/08/25	15.63KB	Share
FRE	Appendix 4G		29/08/25	272.24KB	Share
FRE	Corporate Governance Statement		29/08/25	322.09KB	Share
FRE	Appendix 4E and Annual Report 30 June 2025	PRICE SENSITIVE	29/08/25	2.03MB	Share
FRE	Proposed issue of securities - FRE		26/08/25	16.45KB	Share
FRE	Firebrick Secures $1.4 million via Placement	PRICE SENSITIVE	26/08/25	249.41KB	Share
FRE	License Agreement for Singapore, Malaysia, Brunei, Mauritius	PRICE SENSITIVE	26/08/25	145.39KB	Share
FRE	Nasodine COVID-19 Patent Granted in Australia		25/08/25	147.45KB	Share
FRE	Nasodine COVID-19 Patent Accepted in Europe		13/08/25	136.88KB	Share
FRE	Notification regarding unquoted securities - FRE		01/08/25	17.93KB	Share
FRE	Initial Director's Interest Notice - Rick Legleiter		01/08/25	239.63KB	Share
FRE	Notification of cessation of securities - FRE		30/07/25	12.87KB	Share
FRE	Proposed issue of securities - FRE		28/07/25	16.16KB	Share
FRE	Firebrick Appoints Rick Legleiter as Director		28/07/25	210.47KB	Share
FRE	June 2025 Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	23/07/25	361.44KB	Share
FRE	Notification regarding unquoted securities - FRE		04/07/25	17.92KB	Share
FRE	Cleansing Notice		04/07/25	230.32KB	Share
FRE	Application for quotation of securities - FRE		04/07/25	15.68KB	Share
FRE	Proposed issue of securities - FRE		26/06/25	18.75KB	Share
FRE	Firebrick Closes Placement at $0.2 milliion	PRICE SENSITIVE	26/06/25	248.26KB	Share
FRE	Trading Halt	PRICE SENSITIVE	24/06/25	332.05KB	Share
FRE	Firebrick Pharma Investor Presentation 23 June 2025		23/06/25	3.37MB	Share
FRE	Nasodine Phase 3 Common Cold Trial Published		10/06/25	133.93KB	Share
FRE	Withdrawal of Share Placement	PRICE SENSITIVE	06/06/25	95.37KB	Share
FRE	Trading Halt	PRICE SENSITIVE	05/06/25	329.81KB	Share
FRE	March 2025 Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	16/04/25	603.25KB	Share
FRE	Cleansing Notice		28/03/25	216.86KB	Share
FRE	Application for quotation of securities - FRE		28/03/25	15.61KB	Share
FRE	Cleansing Notice		21/03/25	229.49KB	Share
FRE	Application for quotation of securities - FRE		21/03/25	15.61KB	Share
FRE	Becoming a substantial holder - Pharma Nutria NA Inc		06/03/25	273.63KB	Share
FRE	Becoming a substantial holder - Firebrick Pharma		06/03/25	176.25KB	Share
FRE	Change in substantial holding - Stephen Goodall		06/03/25	1.52MB	Share
FRE	Change in substantial holding - Peter Molloy		06/03/25	1.37MB	Share
FRE	Cleansing Notice		05/03/25	229.23KB	Share
FRE	Application for quotation of securities - FRE		05/03/25	15.53KB	Share
FRE	Proposed issue of securities - FRE		04/03/25	15.46KB	Share
FRE	FRE secures Strategic Investment from Philippines Partner	PRICE SENSITIVE	04/03/25	299.72KB	Share
FRE	Trading Halt	PRICE SENSITIVE	28/02/25	618.38KB	Share
FRE	Webinar on Firebrick Half-Year Results and 2025 Plans		20/02/25	110.99KB	Share
FRE	Appendix 4D & Half-Year Financial Report to 31 December 2024	PRICE SENSITIVE	20/02/25	832.34KB	Share
FRE	Nasodine to be Launched in Fiji and South Pacific		12/02/25	106.64KB	Share
FRE	December 2024 Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	23/01/25	304.67KB	Share
FRE	Successful Nasodine Patent Defense in Singapore		13/01/25	107.11KB	Share
FRE	Notification regarding unquoted securities - FRE		20/12/24	17.43KB	Share
FRE	Proposed issue of securities - FRE		19/12/24	16.35KB	Share
FRE	Consulting Agreement Extended to Grow Asia Sales		19/12/24	246.87KB	Share
FRE	Results of Annual General Meeting		27/11/24	130.01KB	Share
FRE	Annual General Meeting Presentation		27/11/24	1.09MB	Share
FRE	Nasodine Retail Pharmacy Launch in Singapore	PRICE SENSITIVE	25/11/24	116.21KB	Share
FRE	Nasodine COVID-19 Patent Allowed in Mexico		01/11/24	138.53KB	Share
FRE	Agreement Signed to Market Nasodine to HCPs in Singapore	PRICE SENSITIVE	31/10/24	126.13KB	Share
FRE	Letter to Shareholders & Notice of AGM & Proxy Form		28/10/24	556.32KB	Share
FRE	September 2024 Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	22/10/24	324.5KB	Share
FRE	Cleansing Notice		16/10/24	230.5KB	Share
FRE	Application for quotation of securities - FRE		16/10/24	15.51KB	Share
FRE	Change of Director's Interest Notice - Stephen Goodall		10/10/24	275.76KB	Share
FRE	Change of Director's Interest Notice - Peter Molloy		10/10/24	297.14KB	Share
FRE	Proposed issue of securities - FRE		10/10/24	16.65KB	Share
FRE	Application for quotation of securities - FRE		10/10/24	15.39KB	Share
FRE	Completion of Share Purchase Plan	PRICE SENSITIVE	10/10/24	112.82KB	Share
FRE	Firebrick Investor Update Webinar Recording		01/10/24	109.75KB	Share
FRE	Final Director's Interest Notice - Richard Treagus		01/10/24	254.64KB	Share
FRE	Notice of AGM and Closing Date for Director Nominations		30/09/24	129.23KB	Share
FRE	Firebrick Investor Update		25/09/24	1.75MB	Share
FRE	Firebrick receives $0.9 million R&D Tax Incentive	PRICE SENSITIVE	23/09/24	103.93KB	Share
FRE	Share Purchase Plan Open		17/09/24	446.28KB	Share
FRE	Cleansing Notice Pursuant to Share Purchase Plan		17/09/24	119.21KB	Share
FRE	Resignation of Director Dr Richard Treagus		12/09/24	96.85KB	Share
FRE	Proposed issue of securities - FRE		12/09/24	17.56KB	Share
FRE	Share Purchase Plan	PRICE SENSITIVE	12/09/24	107.49KB	Share
FRE	Notification regarding unquoted securities - FRE		10/09/24	17.83KB	Share
FRE	Proposed issue of securities - FRE		09/09/24	16.24KB	Share
FRE	FRE Consultant to Drive Pharmacy Distribution in Singapore		09/09/24	271.45KB	Share
FRE	Nasodine European Marketing Application Filed and Validated		09/09/24	110.19KB	Share
FRE	Cleansing Notice		04/09/24	230.45KB	Share
FRE	Application for quotation of securities - FRE		04/09/24	15.65KB	Share
FRE	Appendix 4G		30/08/24	268.44KB	Share
FRE	Corporate Governance Statement		30/08/24	323.39KB	Share
FRE	Appendix 4E and Annual Report 30 June 2024	PRICE SENSITIVE	30/08/24	2.11MB	Share
FRE	New agreement allows Nasodine launch in Philippines	PRICE SENSITIVE	15/08/24	142.19KB	Share
FRE	June 2024 Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	30/07/24	366.32KB	Share
FRE	Change of Director's Interest Notice - Peter Molloy		28/06/24	296.7KB	Share
FRE	Nasodine Phase 1 Paper Published		17/06/24	164.27KB	Share
FRE	Firebrick Launches Nasodine in Singapore	PRICE SENSITIVE	13/06/24	300.06KB	Share
FRE	Change in substantial holding		04/06/24	101.17KB	Share
FRE	Notification regarding unquoted securities - FRE		29/05/24	17.39KB	Share

FRE Final Director's Interest Notice - Phyllis Gardner
12/09/25		254.96KB	Share
FRE Passing of Director - Phyllis Gardner
11/09/25		125.58KB	Share
FRE Cleansing Notice
11/09/25		131.46KB	Share
FRE Application for quotation of securities - FRE
11/09/25		15.81KB	Share
FRE Firebrick receives $250,000 R&D Tax Incentive
10/09/25	PRICE SENSITIVE	127.6KB	Share
FRE Ceasing to be a substantial holder - Pharma Nutria NA Inc
02/09/25		317.39KB	Share
FRE Change in substantial holding
01/09/25		111.3KB	Share
FRE Change in substantial holding - Peter Molloy
29/08/25		278.08KB	Share
FRE Change in substantial holding - Stephen Goodall
29/08/25		188.32KB	Share
FRE Ceasing to be a substantial holder - Firebrick Pharma
29/08/25		203.91KB	Share
FRE Cleansing Notice
29/08/25		131.56KB	Share
FRE Notification regarding unquoted securities - FRE
29/08/25		14.45KB	Share
FRE Application for quotation of securities - FRE
29/08/25		15.7KB	Share
FRE Application for quotation of securities - FRE
29/08/25		15.63KB	Share
FRE Appendix 4G
29/08/25		272.24KB	Share
FRE Corporate Governance Statement
29/08/25		322.09KB	Share
FRE Appendix 4E and Annual Report 30 June 2025
29/08/25	PRICE SENSITIVE	2.03MB	Share
FRE Proposed issue of securities - FRE
26/08/25		16.45KB	Share
FRE Firebrick Secures $1.4 million via Placement
26/08/25	PRICE SENSITIVE	249.41KB	Share
FRE License Agreement for Singapore, Malaysia, Brunei, Mauritius
26/08/25	PRICE SENSITIVE	145.39KB	Share
FRE Nasodine COVID-19 Patent Granted in Australia
25/08/25		147.45KB	Share
FRE Nasodine COVID-19 Patent Accepted in Europe
13/08/25		136.88KB	Share
FRE Notification regarding unquoted securities - FRE
01/08/25		17.93KB	Share
FRE Initial Director's Interest Notice - Rick Legleiter
01/08/25		239.63KB	Share
FRE Notification of cessation of securities - FRE
30/07/25		12.87KB	Share
FRE Proposed issue of securities - FRE
28/07/25		16.16KB	Share
FRE Firebrick Appoints Rick Legleiter as Director
28/07/25		210.47KB	Share
FRE June 2025 Quarterly Activity Report & Appendix 4C
23/07/25	PRICE SENSITIVE	361.44KB	Share
FRE Notification regarding unquoted securities - FRE
04/07/25		17.92KB	Share
FRE Cleansing Notice
04/07/25		230.32KB	Share
FRE Application for quotation of securities - FRE
04/07/25		15.68KB	Share
FRE Proposed issue of securities - FRE
26/06/25		18.75KB	Share
FRE Firebrick Closes Placement at $0.2 milliion
26/06/25	PRICE SENSITIVE	248.26KB	Share
FRE Trading Halt
24/06/25	PRICE SENSITIVE	332.05KB	Share
FRE Firebrick Pharma Investor Presentation 23 June 2025
23/06/25		3.37MB	Share
FRE Nasodine Phase 3 Common Cold Trial Published
10/06/25		133.93KB	Share
FRE Withdrawal of Share Placement
06/06/25	PRICE SENSITIVE	95.37KB	Share
FRE Trading Halt
05/06/25	PRICE SENSITIVE	329.81KB	Share
FRE March 2025 Quarterly Activity Report & Appendix 4C
16/04/25	PRICE SENSITIVE	603.25KB	Share
FRE Cleansing Notice
28/03/25		216.86KB	Share
FRE Application for quotation of securities - FRE
28/03/25		15.61KB	Share
FRE Cleansing Notice
21/03/25		229.49KB	Share
FRE Application for quotation of securities - FRE
21/03/25		15.61KB	Share
FRE Becoming a substantial holder - Pharma Nutria NA Inc
06/03/25		273.63KB	Share
FRE Becoming a substantial holder - Firebrick Pharma
06/03/25		176.25KB	Share
FRE Change in substantial holding - Stephen Goodall
06/03/25		1.52MB	Share
FRE Change in substantial holding - Peter Molloy
06/03/25		1.37MB	Share
FRE Cleansing Notice
05/03/25		229.23KB	Share
FRE Application for quotation of securities - FRE
05/03/25		15.53KB	Share
FRE Proposed issue of securities - FRE
04/03/25		15.46KB	Share
FRE FRE secures Strategic Investment from Philippines Partner
04/03/25	PRICE SENSITIVE	299.72KB	Share
FRE Trading Halt
28/02/25	PRICE SENSITIVE	618.38KB	Share
FRE Webinar on Firebrick Half-Year Results and 2025 Plans
20/02/25		110.99KB	Share
FRE Appendix 4D & Half-Year Financial Report to 31 December 2024
20/02/25	PRICE SENSITIVE	832.34KB	Share
FRE Nasodine to be Launched in Fiji and South Pacific
12/02/25		106.64KB	Share
FRE December 2024 Quarterly Activity Report & Appendix 4C
23/01/25	PRICE SENSITIVE	304.67KB	Share
FRE Successful Nasodine Patent Defense in Singapore
13/01/25		107.11KB	Share
FRE Notification regarding unquoted securities - FRE
20/12/24		17.43KB	Share
FRE Proposed issue of securities - FRE
19/12/24		16.35KB	Share
FRE Consulting Agreement Extended to Grow Asia Sales
19/12/24		246.87KB	Share
FRE Results of Annual General Meeting
27/11/24		130.01KB	Share
FRE Annual General Meeting Presentation
27/11/24		1.09MB	Share
FRE Nasodine Retail Pharmacy Launch in Singapore
25/11/24	PRICE SENSITIVE	116.21KB	Share
FRE Nasodine COVID-19 Patent Allowed in Mexico
01/11/24		138.53KB	Share
FRE Agreement Signed to Market Nasodine to HCPs in Singapore
31/10/24	PRICE SENSITIVE	126.13KB	Share
FRE Letter to Shareholders & Notice of AGM & Proxy Form
28/10/24		556.32KB	Share
FRE September 2024 Quarterly Activity Report & Appendix 4C
22/10/24	PRICE SENSITIVE	324.5KB	Share
FRE Cleansing Notice
16/10/24		230.5KB	Share
FRE Application for quotation of securities - FRE
16/10/24		15.51KB	Share
FRE Change of Director's Interest Notice - Stephen Goodall
10/10/24		275.76KB	Share
FRE Change of Director's Interest Notice - Peter Molloy
10/10/24		297.14KB	Share
FRE Proposed issue of securities - FRE
10/10/24		16.65KB	Share
FRE Application for quotation of securities - FRE
10/10/24		15.39KB	Share
FRE Completion of Share Purchase Plan
10/10/24	PRICE SENSITIVE	112.82KB	Share
FRE Firebrick Investor Update Webinar Recording
01/10/24		109.75KB	Share
FRE Final Director's Interest Notice - Richard Treagus
01/10/24		254.64KB	Share
FRE Notice of AGM and Closing Date for Director Nominations
30/09/24		129.23KB	Share
FRE Firebrick Investor Update
25/09/24		1.75MB	Share
FRE Firebrick receives $0.9 million R&D Tax Incentive
23/09/24	PRICE SENSITIVE	103.93KB	Share
FRE Share Purchase Plan Open
17/09/24		446.28KB	Share
FRE Cleansing Notice Pursuant to Share Purchase Plan
17/09/24		119.21KB	Share
FRE Resignation of Director Dr Richard Treagus
12/09/24		96.85KB	Share
FRE Proposed issue of securities - FRE
12/09/24		17.56KB	Share
FRE Share Purchase Plan
12/09/24	PRICE SENSITIVE	107.49KB	Share
FRE Notification regarding unquoted securities - FRE
10/09/24		17.83KB	Share
FRE Proposed issue of securities - FRE
09/09/24		16.24KB	Share
FRE FRE Consultant to Drive Pharmacy Distribution in Singapore
09/09/24		271.45KB	Share
FRE Nasodine European Marketing Application Filed and Validated
09/09/24		110.19KB	Share
FRE Cleansing Notice
04/09/24		230.45KB	Share
FRE Application for quotation of securities - FRE
04/09/24		15.65KB	Share
FRE Appendix 4G
30/08/24		268.44KB	Share
FRE Corporate Governance Statement
30/08/24		323.39KB	Share
FRE Appendix 4E and Annual Report 30 June 2024
30/08/24	PRICE SENSITIVE	2.11MB	Share
FRE New agreement allows Nasodine launch in Philippines
15/08/24	PRICE SENSITIVE	142.19KB	Share
FRE June 2024 Quarterly Activity Report & Appendix 4C
30/07/24	PRICE SENSITIVE	366.32KB	Share
FRE Change of Director's Interest Notice - Peter Molloy
28/06/24		296.7KB	Share
FRE Nasodine Phase 1 Paper Published
17/06/24		164.27KB	Share
FRE Firebrick Launches Nasodine in Singapore
13/06/24	PRICE SENSITIVE	300.06KB	Share
FRE Change in substantial holding
04/06/24		101.17KB	Share
FRE Notification regarding unquoted securities - FRE
29/05/24		17.39KB	Share

REFRESH

1 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 6.5¢		Change 0.000(0.00%)		Mkt cap ! $16.27M

Open	High	Low	Value	Volume
6.8¢	6.8¢	6.5¢	$1.129K	17K

Buyers (Bids)

No.	Vol.	Price($)
1	24891	6.5¢

Sellers (Offers)

Price($)	Vol.	No.
6.8¢	79497	2

View Market Depth

No.	Vol.	Price($)
1	24891	0.065
1	80000	0.063
1	100000	0.062
3	46000	0.060
1	18155	0.055

Price($)	Vol.	No.
0.068	79497	2
0.071	210909	1
0.078	27030	1
0.079	301590	2
0.083	120000	1

Last trade - 12.22pm 19/09/2025 (20 minute delay)

FRE (ASX) Chart

FIREBRICK PHARMA LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available